Compare AIR & VCYT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AIR | VCYT |
|---|---|---|
| Founded | 1951 | 2006 |
| Country | United States | United States |
| Employees | 5600 | N/A |
| Industry | Aerospace | Medical Specialities |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.3B | 2.9B |
| IPO Year | 1988 | 2013 |
| Metric | AIR | VCYT |
|---|---|---|
| Price | $82.43 | $44.65 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 8 |
| Target Price | ★ $89.00 | $45.38 |
| AVG Volume (30 Days) | 346.9K | ★ 978.7K |
| Earning Date | 01-06-2026 | 11-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.81 | 0.38 |
| Revenue | ★ $2,858,400,000.00 | $495,141,000.00 |
| Revenue This Year | $12.82 | $16.02 |
| Revenue Next Year | $9.18 | $10.74 |
| P/E Ratio | ★ $102.23 | $117.27 |
| Revenue Growth | ★ 17.59 | 16.41 |
| 52 Week Low | $46.51 | $22.61 |
| 52 Week High | $89.69 | $50.71 |
| Indicator | AIR | VCYT |
|---|---|---|
| Relative Strength Index (RSI) | 51.71 | 55.12 |
| Support Level | $80.90 | $45.68 |
| Resistance Level | $84.78 | $48.10 |
| Average True Range (ATR) | 2.50 | 2.17 |
| MACD | 0.34 | -0.02 |
| Stochastic Oscillator | 71.64 | 51.69 |
AAR Corp is engaged in providing products and services to aviation, government and defense market. It operates in segments namely: The parts supply segment majorly consists of sales and leasing of USM and aftermarket distribution of new, OEM-supplied replacement parts; Repair & Engineering segment provides airframe maintenance, component repair, and landing gear overhaul services; Integrated Solutions segment consists of its fleet management and operations of customer-owned aircraft, customized performance-based supply chain logistics programs in support of the U.S. Department of Defense, flight hour component inventory; and The Expeditionary Services segment consists of products and services supporting the movement of equipment and personnel by the U.S. and foreign governments and NGOs.
Veracyte Inc is a genomic diagnostics company. The group empowers clinicians with the insights necessary to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. It offers tests for prostate cancer (Decipher Prostate), thyroid cancer (Afirma), breast cancer (Prosigna), and bladder cancer (Decipher Bladder). In addition, its Percepta Nasal Swab test is being run in CLIA labs in support of clinical studies.